Metacrine, Inc.
MTCRDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001634379
Metacrine, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Mar 24, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $7.29M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Metacrine, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 31 | 31 | 0 |
| Shares | 3.30M | 6.29M | +2.98M (+90.4%) |
| Value | $2.23M | $3.83M | +$1.61M (+72.3%) |
New holders (8)
Institutions that held Metacrine, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,940,503 | $1.79M | 0.26% |
| Bank of New York Mellon Corp | 207,019 | $126.0K | 0.00% |
| Crestline Management, LP | 160,714 | $98.0K | 0.01% |
| Two Sigma Investments, LP | 23,035 | $14.0K | 0.00% |
| Ergoteles LLC | 12,432 | $8.00K | 0.00% |
| Barclays PLC | 11,710 | $7.00K | 0.00% |
| Citigroup Inc | 2,982 | $2.00K | 0.00% |
| JPMorgan Chase & Co | 1,038 | $1.00K | 0.00% |
Sold out (8)
Institutions that held Metacrine, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Virtu Financial LLC | 122,366 | $82.0K |
| Acadian Asset Management LLC | 84,442 | $56.0K |
| Engineers Gate Manager LP | 81,497 | $55.0K |
| Millennium Management LLC | 71,017 | $48.0K |
| Jane Street Group, LLC | 69,003 | $47.0K |
| HRT Financial LP | 23,589 | $15.0K |
| Cim Investment Mangement Inc | 19,054 | $13.0K |
| Simplex Trading, LLC | 2,462 | $1.00K |